Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announces that it has signed a definitive agreement to sell its Advanced Rehabilitation business of its subsidiary, Bioness, to Accelmed Partners (“Accelmed”), a private equity firm focused on acquiring and growing commercial-stage HealthTech companies. The transaction includes a total cash consideration of $45 million, including $25 million in cash at close (subject to a working capital adjustment) and up to $20 million in potential post-closing earn-out payments.
Read the full article: Bioventus Announces Divestiture of Its Advanced Rehabilitation Business to Accelmed Partners //
Source: https://www.globenewswire.com/news-release/2024/10/01/2956208/0/en/Bioventus-Announces-Divestiture-of-its-Advanced-Rehabilitation-Business-to-Accelmed-Partners.html